Trastuzumab (Herceptin (R)) for breast cancer

Record ID 32005000050
Authors' objectives:

Trastuzumab is a recombinant monoclonal antibody that specifically targets the HER-2 protein and is used in the treatment of HER-2 positive breast cancer.

Authors' methods: Review
Project Status: Completed
URL for project:
Year Published: 2004
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
MeSH Terms
  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Breast Neoplasms
  • Trastuzumab
Organisation Name: HAYES, Inc.
Contact Address: 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
Contact Email:
Copyright: HAYES, Inc.
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.